Q-omics provides the consensus-scored LINC00634 profile across patient tissues and cancer cell-line models. LINC00634 expression is associated with patient survival in 24 of 34 cancer types, with the highest sampling consensus in COAD. Among the 18 cancer types available for tumor–normal comparison, LINC00634 is differentially expressed in 14, with the highest sampling consensus in HNSC. Additionally, LINC00634 RNA expression shows 19,500 significant protein co-abundance associations, with the highest sampling consensus in LSCC. Together, these results highlight COAD, HNSC, and LSCC as cancer lineages where LINC00634 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC00634 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC00634 survival associations across molecular data types. LINC00634 RNA expression shows survival associations in the most cancer types (24), followed by mutation status (2). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC00634 RNA expression–survival associations across cancer types. High LINC00634 expression shows unfavorable associations in COAD, ACC, KIRC, LIHC and KIRP, but favorable associations in UVM. The COAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify COAD as the clearest survival context for LINC00634 RNA expression.
This table summarizes LINC00634 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 14. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC00634. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC00634 shows higher tumor expression in HNSC, UCEC, LUSC, COAD, LIHC and BLCA. The HNSC box plot shows higher LINC00634 RNA expression in tumor versus normal tissue (log2 FC = +0.393, t-test p < 0.001).
This table shows molecular features associated with LINC00634 in patient tissues and cancer cell lines. In patient samples, LINC00634 shows the broadest associations at the RNA and protein expression levels, with LSCC recurring as the lineage with the largest associated feature set.
